Bank of New York Mellon’s ARMO BioSciences, Inc. Common Stock ARMO Stock Holding History

Bank of New York Mellon’s Portfolio ARMO Stock Details ARMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-20,322	Closed	-$761K	–	4380
2018 Q1	$761K	Buy	+20,322	New	+$854K	﹤0.01%	3357

Bank of New York Mellon's ARMO Position: Q2 2018 in Review

Bank of New York Mellon sold out of ARMO BioSciences, Inc. Common Stock (ARMO) in Q2 2018, closing a stake of 20,322 shares — an estimated $761K sold.

Bank of New York Mellon first reported a position in ARMO in Q1 2018 and held it in 1 quarter. The position peaked at $761K in Q1 2018. 0 funds tracked by Wall St. Rank hold ARMO as of Q2 2018.

Bank of New York Mellon reported no remaining ARMO BioSciences, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
Bank of New York Mellon sold 20,322 ARMO BioSciences, Inc. Common Stock shares in Q2 2018, an estimated $761K.
Bank of New York Mellon first reported a position in ARMO BioSciences, Inc. Common Stock in Q1 2018 and held it in 1 quarter.
Bank of New York Mellon's ARMO BioSciences, Inc. Common Stock position peaked at $761K in Q1 2018.
0 funds tracked by Wall St. Rank held ARMO BioSciences, Inc. Common Stock as of Q2 2018.

Based on Bank of New York Mellon's 13F filing for Q2 2018, filed 6 Aug 2018.